Vol. 42 (4): 635-636, July – August, 2016
doi: 10.1590/S1677-5538.IBJU.2016.04.01
EDITORIAL In this issue
Luciano A. Favorito 1-3
1 Professor Associado da Unidade de Pesquisa Urogenital da Universidade do Estado de Rio de Janeiro, RJ, Brasil; 2 Urologista do Hospital da Lagoa Federal,Rio de Janeiro RJ, Brasil; 3 Editor Associado do International Braz J Urol, RJ, Brasil
The July-August 2016 issue of the International Braz J Urol presents original contributions with a lot of interesting papers in different fields: Urinary Incontinence, Pyelonephritis, Bladder Cancer, BPH, Prostate Cancer, Renal stones, Renal Cell Carcinoma, Uroginecology, Pediatric Urology and basic research. The papers come from many different countries such as Brazil, USA, Turkey, Italy, Israel, India, China, Iran, Thailand, Egypt, Korea and Colombia, and as usual the editor’s comment highlights some papers.
We decided to comment 3 papers about a very usual topic in urologic practice: Benign Prostatic Hyperplasia.
Doctor Kobayashi and collegues from Japan performed on page 740 an interesting study about the predictive risk factors of postoperative urinary incontinence following holmium laser enucleation (HoLEP). The authors evaluated 127 patients with benign prostatic hyperplasia who underwent HoLEP. The authors observed that a postoperative urinary incontinence (UI) occurred in 31 patients (24.4%), but it cured in 29 patients (93.5%) after a mean duration of 12 weeks. They concluded that longer enucleation time and increased blood loss were independent predictors of postoperative UI in patients who underwent HoLEP during the initial learning period.
